Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin in Japanese Type 2 Diabetes
NCT00628212Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Mitsubishi Tanabe Pharma. Started Jan 2008; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00628212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628212.